Raju Khubchandani
Overview
Explore the profile of Raju Khubchandani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gagne S, Sivaraman V, Bosman E, Klamer B, Morishita K, Huber A, et al.
Arthritis Care Res (Hoboken)
. 2024 Oct;
PMID: 39467015
Objective: Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are chronic life-threatening vasculitides requiring substantial immunotherapy. Adult trials identified rituximab (RTX) as an alternative to cyclophosphamide (CYC) for remission induction...
2.
Sil A, Basu S, Arora K, Khubchandani R, Rawat A, Suri D
J Clin Immunol
. 2024 Aug;
44(8):187.
PMID: 39215847
Autosomal recessive agammaglobulinemia is a severe primary antibody deficiency disorder typically presenting in infancy. We present a rare case of an 8-year-old boy with AR agammaglobulinemia due to a homozygous...
3.
Triaille C, Rao N, Rice G, Seabra L, Sutherland F, Bondet V, et al.
J Clin Immunol
. 2024 Aug;
44(8):185.
PMID: 39196411
Hereditary C1q deficiency (C1QDef) is a rare monogenic disorder leading to defective complement pathway activation and systemic lupus erythematosus (SLE)-like manifestations. The link between impairment of the complement cascade and...
4.
Baldo F, Erkens R, Mizuta M, Rogani G, Lucioni F, Bracaglia C, et al.
Rheumatology (Oxford)
. 2024 Jul;
64(1):32-44.
PMID: 39058514
Objective: To assess current treatment in macrophage activation syndrome (MAS) worldwide and to highlight any areas of major heterogeneity of practice. Methods: A systematic literature search was performed in both...
5.
Rosina S, Rebollo-Gimenez A, Tarantola L, Pistorio A, Vyzhga Y, Miedany Y, et al.
Arthritis Rheumatol
. 2024 Apr;
76(9):1446-1454.
PMID: 38682570
Objective: Our objective was to develop and validate cutoff values in the systemic Juvenile Arthritis Disease Activity Score 10 (sJADAS10) that distinguish the states of inactive disease (ID), minimal disease...
6.
Khubchandani R, Avcin T, Ravelli A
Pediatr Rheumatol Online J
. 2023 Dec;
21(1):145.
PMID: 38105249
Introduction: Much has been written and spoken about telemedicine since about two decades including an article in this journal at the start of the pandemic. It took a global catastrophe...
7.
Maldar N, Khubchandani R, Khan A
Indian J Pediatr
. 2023 Sep;
91(9):934-940.
PMID: 37736825
Just under a decade ago, most children with genetic disorders received a phenotypic diagnosis, often by atlas matching. With advances in genomics (decoding of human genome, easy availability of genetic...
8.
Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri M, Sakamoto A, et al.
J Scleroderma Relat Disord
. 2023 Jun;
8(2):120-130.
PMID: 37287945
Objective: To compare organ involvement and disease severity between male and female patients with juvenile onset systemic sclerosis. Methods: Demographics, organ involvement, laboratory evaluation, patient-reported outcomes and physician assessment variables...
9.
Toplak N, Pimpale Chavan P, Rosina S, Dallos T, Rotem Semo O, Aguiar C, et al.
Front Pediatr
. 2022 Mar;
9:810785.
PMID: 35280444
Juvenile dermatomyositis (JDM) has a wide spectrum of clinical presentations. In the last decade, several myositis-specific antibodies have been identified in patients with JDM and connected with specific organ involvement...
10.
Taft J, Markson M, Legarda D, Patel R, Chan M, Malle L, et al.
Cell
. 2021 Aug;
184(17):4447-4463.e20.
PMID: 34363755
TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26,...